Quicklinks by Audience
Our Mission
To reduce the burden of cancer through transformational science and innovative therapies, an emphasis on prevention, patient-centered care, and cancer health disparities, and a culture of community engagement and workforce opportunity.
The Future of Cancer Care, Today.
Transdisciplinary Research
UT Southwestern physicians and scientists conduct laboratory research, clinical research, and population-based research, leading to new drugs and treatments – with the sole purpose of improving patient care and ultimately saving lives.
Promotes research to increase understanding of molecular mechanisms altered in tumor cells and their microenvironment that support cancer initiation and metastatic progression.
Focuses on the discovery of drug-like chemicals that affect biological processes causal to the development and progression of cancer.
Brings together investigators in developmental and cancer stem cell biology to discover how aberrant developmental processes contribute to initiation and progression of cancer.
Promotes, develops, and exploits mechanism-based research for improved therapy of human cancer.
Focuses on cross-cutting themes of cancer health disparities and health services research in the catchment’s safety-net systems, recognizing Dallas’s great socioeconomic and ethnic diversity.
Shared Resources
Key Facts
UT Southwestern provides over a dozen major cancer care programs that advance the treatment and prevention of cancer through innovative therapies, leading-edge clinical trials and the latest technology.
283
Members
37
Departments
823
2024 Member Publications
$33.6M
NCI Direct Cost Funding
*Data as of 8/1/2024
$82.2M
Peer-Reviewed Direct Cost Funding
*Data as of 4/1/2025
$119.6M
Overall Direct Cost Extramural Funding
*Data as of 4/1/2025
1330
2024 Interventional Clinical Trial Accrual
787
2024 Therapeutic Trial Accrual
535
Active Clinical Trials
State-of-the-Art Research & Clinical Facilities
National Cancer Institute (NCI)-designated
- The top cancer specialists in the country
- Cutting-edge therapies
- Seamless disease-oriented teams collaborating for each patient
- A broad array of treatment options
- Leading-edge clinical trials
- The most advanced technology and equipment
- State-of-the-art clinics and hospitals
National Comprehensive Cancer Network
NCCN is a nonprofit alliance of 30 distinguished comprehensive cancer centers throughout the United States, including Harvard, Yale, and the Mayo Clinic. As a NCCN Member Institution, Simmons integrates multidisciplinary teams to provide:
- High-quality patient care
- Depth and breadth of research
- Education across all cancer disciplines
Message from the Director
World renowned breast cancer specialist and investigator
Associate Dean of Oncology Programs
The Harold C. Simmons Comprehensive Cancer Center is one of the world’s premier institutions for important and innovative basic science cancer research, along with being a respected home for diagnosis and treatment of the disease. Our designation by the National Cancer Institute as a Comprehensive Cancer Center – one of only a few across the entire country – testifies to that. Continue reading.